Slowdown in Germany: What Will Happen to These German ADRs?
What's the outlook for Deutsche Bank, Siemens, and Fresenius Medical Care?
The Single Biggest Development in 2013 for Keryx Biopharmaceuticals
Keryx Biopharmaceuticals erupted higher in 2013 on positive results for its lone drug. Approval could be bad news for Sanofi and Fresenius. Need a refresher?
Rockwell Medical: 3 Investing Takeaways From 2013
What three investing lessons can we learn from Rockwell Medical's 70% climb over the past year? How does Rockwell relate to dialysis service providers DaVita Healthcare Partners and Fresenius Medical Care, as well as biotech giant Amgen?